Finland · Delayed Price · Currency is EUR Biohit Oyj Company Description
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.
The company offers GastroPanel quick test NT, a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori and atrophic gastritis; GastroPanel test, a blood test for diagnosis of the function and structure of stomach mucosa; GastroSoft, a software application designed to assist clinicians and general practitioners in interpreting GastroPanel test results; and GP Reader NT for the quantitative determination of various analytes in human samples.
It also provides BIOHIT active B12 (HoloTC) test, BIOHIT total 25OH vitamin D test, and BIOHIT Calprotectin; BIOHIT ColonView quick test for detection of fecal occult blood (FOB) in stool samples; BIOHIT Celiac quick test, a qualitative in vitro immunochromatographic test aiding in diagnosis of celiac disease; BIOHIT H.
pylori UFT300 and H.pylori tests for the diagnosis of H,pylori infection; lactose intolerance quick test kit; and Gluten Immunogenic Peptides test.
In addition, it offers Acetium acetaldehyde binding products, such as the Acetium lozenge to help quit smoking and Acetium capsule for the protection of the stomach.
Further, the company provides monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research.
Additionally, it offers BIOHIT FAEX sample system for the collection and handling of stool samples. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.
| Country | Finland |
| Founded | 1988 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Jussi Hahtela |
Contact Details
Address: Laippatie 1 Helsinki, 00880 Finland | |
| Phone | 358 9 773 861 |
| Website | biohithealthcare.com |
Stock Details
| Ticker Symbol | BIOBV |
| Exchange | Nasdaq Helsinki |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FI0009005482 |
| SIC Code | 3821 |
Key Executives
| Name | Position |
|---|---|
| Jussi Hahtela | President and Chief Executive Officer |
| Prof. Osmo Antero Suovaniemi M.D., Ph.D. | Founder, Deputy Chief Executive Officer, Member of Scientific Advisory Board and Director |
| Jussi Sorvo | Chief Financial Officer |
| Kati Piironen | Chief Technology Officer |
| Ville Suovaniemi | Head of Global Sales and Marketing |
| Yulia Kubacheva | Head of Diagnostics Department - Biohit Russia |
| Graham Johnson B.Sc. | Managing Director of Biohit Healthcare Ltd - UK |